Komori
Hosokawa Micron (6277) · InitiativeRestated

Continued Research and Development Activities

First written in FY2016-Q3. 22 of 30 entries say "Restated". Latest entry: FY2026-H1.

30entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q1 – FY2021-Q22016: 220162017: 320172018: 420182019: 320192020: 220202021: 320212022: 420222023: 420232024: 320242025: 120252026: 1
Same theme, other companies
Continuation of R&D activities with no change in statusA theme 212 companies write about · 0 as a headwind · 201 as a tailwind

93 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 216 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「The total research and development expenses for the current interim consolidated fiscal year were ¥724 million. There were no material changes in the status of the Group's research and development activities during the current interim consolidated fiscal year.」

    It was stated that ¥724 million in research and development expenses was recorded and that there were no material changes in the status of research and development activities.
  2. FY2025-H1RestatedAnnual report

    「The total research and development expenses for the current interim consolidated fiscal year were ¥572 million. There were no material changes in the status of the Group's research and development activities during the current interim consolidated fiscal year.」

    It was stated that research and development expenses for the current interim period were ¥572 million and that there were no material changes in the status of research and development activities.
  3. FY2024AdvancedAnnual report

    「The total research and development expenses for the Group as a whole for the current consolidated fiscal year were ¥1,145 million.」

    Research and development expenses increased from ¥998 million in the previous fiscal year to ¥1,145 million. The Group continued to develop ultrafine particle mills, high-performance classifiers, energy-saving dryers, IIoT and nanotechnology, and completed its nanoral technology.
  4. FY2024-Q2RestatedAnnual report

    「The total research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥542 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」

    It was stated that research and development expenses for the cumulative second quarter were ¥542 million and that there were no material changes in the status of research and development activities.
  5. FY2024-Q1RestatedAnnual report

    「The total research and development expenses for the cumulative first quarter of the current consolidated fiscal year were ¥244 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」

    It was stated that ¥244 million in research and development expenses was recorded for the first quarter and that there were no material changes in the status of research and development activities.
  6. FY2023AdvancedAnnual report

    「The total research and development expenses for the Group as a whole for the current consolidated fiscal year were ¥998 million.」

    Research and development expenses increased from ¥888 million in the previous fiscal year to ¥998 million. The Group continued to develop and commercialize ultrafine particle mills, high-performance classifiers, energy-saving dryers, particle-shape measurement equipment, IIoT, nanotechnology and other technologies.
  7. FY2023-Q3RestatedAnnual report

    「The total research and development expenses for the cumulative third quarter of the current consolidated fiscal year were ¥710 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」

    It was stated that research and development expenses for the cumulative third quarter were ¥710 million and that there were no material changes in the status of research and development activities.
  8. FY2023-Q2RestatedAnnual report

    「The total research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥458 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」

    It was stated that ¥458 million in research and development expenses was recorded for the cumulative second quarter and that there were no material changes in the status of research and development activities.
  9. FY2023-Q1RestatedAnnual report

    「The total research and development expenses for the cumulative first quarter of the current consolidated fiscal year were ¥237 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」

    It was stated that ¥237 million in research and development expenses was recorded for the first quarter and that there were no material changes in the status of research and development activities.
  10. FY2022AdvancedAnnual report

    「The total research and development expenses for the Group as a whole for the current consolidated fiscal year were ¥888 million.」

    Recorded ¥888 million in research and development expenses and advanced the development and commercialization of ultrafine particle mills, high-performance classifiers, energy-saving dryers, particle-shape measurement equipment, IIoT, PLGA-based products and other technologies.
  11. FY2022-Q3RestatedAnnual report

    「The total research and development expenses for the cumulative third quarter of the current consolidated fiscal year were ¥651 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」

    It was stated that research and development expenses for the cumulative third quarter were ¥651 million and that there were no material changes in the status of research and development activities.
  12. FY2022-Q2RestatedAnnual report

    「The total research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥433 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter of the current consolidated fiscal year.」

    It was stated that research and development expenses for the cumulative second quarter were ¥433 million and that there were no material changes in the status of research and development activities.
  13. FY2022-Q1RestatedAnnual report

    「The total research and development expenses for the cumulative first quarter of the current consolidated fiscal year were ¥208 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」

    It was stated that ¥208 million in research and development expenses was recorded for the first quarter and that there were no material changes in the status of research and development activities.
  14. FY2021AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the consolidated fiscal year under review were ¥880 million.」

    Recorded ¥880 million in research and development expenses and advanced the development and commercialization of ultrafine particle mills, ultrahigh-speed classifiers, high-performance dryers, particle-shape measurement equipment, IIoT and other technologies.
  15. FY2021-Q2RestatedAnnual report

    「Total research and development expenses for the six-month period of the fiscal year under review were ¥405 million. There were no material changes in the status of the Group's research and development activities during the six-month period of the fiscal year under review.」

    It was reported that there were no material changes in research and development activities, and that research and development expenses for the six-month period were ¥405 million.
  16. FY2021-Q1RestatedAnnual report

    「Total research and development expenses for the three-month period of the fiscal year under review were ¥184 million. There were no material changes in the status of the Group's research and development activities during the three-month period of the fiscal year under review.」

    Research and development expenses for the first quarter were ¥184 million, and it was reported that there were no material changes in the status of research and development activities.
  17. FY2020-Q3RestatedAnnual report

    「Total research and development expenses for the nine-month period of the fiscal year under review were ¥624 million. There were no material changes in the status of the Group's research and development activities during the nine-month period of the fiscal year under review.」

    It was reported that there were no material changes in research and development activities, and that research and development expenses for the nine-month period were ¥624 million.
  18. FY2020-Q1RestatedAnnual report

    「Total research and development expenses for the three-month period of the fiscal year under review were ¥230 million. There were no material changes in the status of the Group's research and development activities during the three-month period of the fiscal year under review.」

    Research and development expenses of ¥230 million were recorded, and it was reported that there were no material changes in the status of research and development activities.
  19. FY2019-Q3RestatedAnnual report

    「Total research and development expenses for the nine-month period of the fiscal year under review were ¥684 million. There were no material changes in the status of the Group's research and development activities during the nine-month period of the fiscal year under review.」

    It was reported that there were no material changes in research and development activities, and that research and development expenses for the nine-month period were ¥684 million.
  20. FY2019-Q2RestatedAnnual report

    「Total research and development expenses for the six-month period of the fiscal year under review were ¥437 million. There were no material changes in the status of the Group's research and development activities during the six-month period of the fiscal year under review.」

    It was reported that there were no material changes in research and development activities, and that research and development expenses for the six-month period were ¥437 million.
  21. FY2019-Q1RestatedAnnual report

    「Total research and development expenses for the three-month period of the fiscal year under review were ¥200 million. There were no material changes in the status of the Group's research and development activities during the three-month period of the fiscal year under review.」

    It was reported that there were no material changes in research and development activities, and that research and development expenses for the three-month period were ¥200 million.
  22. FY2018AdvancedAnnual report

    「Total research and development expenses for the Group as a whole during the consolidated fiscal year under review were ¥923 million.」

    Research and development expenses were ¥923 million, and development and commercialization progressed for products including the ACM Pulverizer F-type, industrial IoT and PLGA-based products.
  23. FY2018-Q3RestatedAnnual report

    「Total research and development expenses for the nine-month period of the fiscal year under review were ¥658 million. There were no material changes in the status of the Group's research and development activities during the nine-month period of the fiscal year under review.」

    Research and development expenses for the nine-month period were ¥658 million, and it was reported that there were no material changes in the status of research and development activities.
  24. FY2018-Q2RestatedAnnual report

    「Total research and development expenses for the six-month period of the fiscal year under review were ¥417 million. There were no material changes in the status of the Group's research and development activities during the six-month period of the fiscal year under review.」

    Research and development expenses for the six-month period were ¥417 million, and it was reported that there were no material changes in the status of research and development activities.
  25. FY2018-Q1RestatedAnnual report

    「Total research and development expenses for the three-month period of the fiscal year under review were ¥194 million. There were no material changes in the status of the Group's research and development activities during the three-month period of the fiscal year under review.」

    Research and development expenses for the first quarter were ¥194 million, and it was reported that there were no material changes in the status of research and development activities.
  26. FY2017AdvancedAnnual report

    「The main research and development activities during the consolidated fiscal year under review were as follows. Total research and development expenses for the Group as a whole during the consolidated fiscal year under review were ¥798 million.」

    Research and development expenses were ¥798 million, and multiple development and commercialization projects progressed, including NOB-VC, PLGA-based products, CR-type classifiers, VCP and VSP dust collectors, and IoT-based remote monitoring.
  27. FY2017-Q3RestatedAnnual report

    「Total research and development expenses for the nine-month period of the fiscal year under review were ¥572 million. There were no material changes in the status of the Group's research and development activities during the nine-month period of the fiscal year under review.」

    It was reported that there were no material changes in research and development activities, and that research and development expenses for the nine-month period were ¥572 million.
  28. FY2017-Q1RestatedAnnual report

    「Total research and development expenses for the three-month period of the fiscal year under review were ¥165 million. There were no material changes in the status of the Group's research and development activities during the three-month period of the fiscal year under review.」

    Research and development activities continued, and research and development expenses for the first quarter were ¥165 million. It was reported that there were no material changes in the status of the activities.
  29. FY2016AdvancedAnnual report

    「Total research and development expenses for the consolidated fiscal year under review were ¥739 million.」

    Research and development continued, with research and development expenses totaling ¥739 million. Specific development results were also reported, including the launch of NOB-VC sales, the granting of a PLGA nanoparticle patent, and demonstration tests of classifiers and granulators.
  30. FY2016-Q3First statedAnnual report

    「Total research and development expenses for the nine-month period of the fiscal year under review were ¥554 million. There were no material changes in the status of the Group's research and development activities during the nine-month period of the fiscal year under review.」

    Research and development activities continued, and research and development expenses for the period were reported as ¥554 million.
Moved together

"Development and Commercialization of New Materials Centered on Composite Nanoparticles" moved the same way as this thread, in the same document, in 7 of its 30 moves.

765555★123456
  1. ★This thread
  2. 1Development and Commercialization of New Materials Centered on Composite Nanoparticles7×
  3. 2Reducing Interest-Bearing Debt Through Repayment of Borrowings6×
  4. 3Profit Improvement Through Margin Expansion and Expense Reduction5×
  5. 4Improvement in sales and profit in the powder-related business5×
  6. 5Stable Shareholder Dividend Payments5×
  7. 6Expanding Core Businesses and Market Areas through Strategic Business Alliances5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Hosokawa Micron's next results are scheduled for 2026-11-06. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.